Background The selection for surgery is multifaceted for patients diagnosed with esophageal cancer. Since it is uncertain how comorbidity should influence the selection, this study addressed comorbidities in relation to risk of severe complications following esophageal cancer surgery. Methods This population-based cohort study was based on prospectively included patients who underwent surgical resection for an esophageal or gastro-esophageal junctional cancer in Sweden during [2001][2002][2003][2004][2005]. The participation rate was 90 %. Associations between pre-defined comorbidities and pre-defined post-operative complications occurring within 30 days of surgery were analyzed using multivariable logistic regression. The resulting odds ratios (ORs) and 95 % confidence intervals (CIs) were adjusted for age, sex, tumor stage, tumor histology, neoadjuvant therapy, type of surgery, annual hospital volume, other comorbidities, and other complications. Results Among 609 included patients, those with cardiac disease (n = 92) experienced an increased risk of predefined complications in general (adjusted OR 1.81, 95 % CI 1.13-2.90), while patients with hypertension (n = 137), pulmonary disorders (n = 79), diabetes (n = 67), and obesity (n = 66) did not. Patients with a Charlson comorbidity index score C2 had substantially increased risks of pre-defined complications (adjusted OR 2.44, 95 % CI 1.60-3.72). Conclusion Cardiac disease and a Charlson comorbidity index score C2 seem to increase the risk of severe and early post-operative complications in patients with esophageal cancer, while hypertension, pulmonary disorders, diabetes, and obesity do not. These findings should be considered in the clinical decision-making for improved selection of patients for surgery.
Introduction
Esophageal cancer is the 6th most common cancer death globally and carries a poor overall prognosis (\15 % 5-year survival) [1] . The 5-year survival after curatively intended therapy, including surgery, is only 30-40 % [2] [3] [4] . Esophagectomy is also associated with a 26-64 % risk of potentially lethal complications [5] [6] [7] [8] [9] , particularly atrial arrhythmia (14-23 %) [5, 9] , anastomotic leaking (4-14 %) [5, 8, 9] , pulmonary complications (10-21 %) [5, 6, 8, 9] , and respiratory failure (6-18 %) [5, 6, 8, 9] . The poor outcomes indicate a need for better selection of patients suitable for surgery, particularly in an era when definite chemoradiotherapy is an alternative for advanced resectable tumors and endoscopic procedures are increasingly being used for early tumors. Comorbidity status could play an important role in patient selection as it is the strongest predictor of early post-operative mortality and other severe complications [2] [3] [4] . The research that has attempted to assess how comorbidity influences post-operative complications is limited and provides little evidence of how to include comorbidity in the pre-operative clinical decision-making [10, 11] . The need for research addressing the role of comorbidities in relation to severe post-operative complications among surgically treated esophageal cancer patients prompted the present study. We conducted a large, population-based and prospectively collected cohort study in Sweden addressing risk of post-operative complications in relation to comorbidities after esophageal cancer surgery with the aim to provide valid scientific evidence of patient selection for surgery in relation to comorbidity.
Patients, materials, and methods

Design
This was a review of a prospectively collected nationwide Swedish (around 9 million inhabitants) population-based cohort study investigating how pre-defined comorbidities (exposure) influence the risk of pre-defined complications occurring within 30 days of esophageal cancer surgery (outcome). The design and organization of this cohort has been presented in detail elsewhere [12, 13] . In brief, the cohort included 90 % of all patients who underwent surgery for esophageal or gastro-esophageal junction cancer, in Sweden between 2nd April 2001 and 31st December 2005. A network of 174 (97 %) out of 179 hospital departments involved in the diagnosis or treatment of esophageal cancer patients provided almost complete national coverage. Non-participation (10 %) was mainly attributed to the five centers that did not contribute. Clinical data on comorbidities, tumor characteristics, pre-operative physical examination, neo-adjuvant therapy, surgical treatment, and post-operative complications were prospectively collected and assessed strictly according to a study form, providing a uniform assessment. The correlation of the data collection between reviewers was assessed as very high [12, 13] . Information on height and weight was self-reported by the patients and used to calculate body mass index (BMI). The cohort was linked to the Swedish Patient Registry, which contains, among other in-hospital variables, codes for diagnoses according to the International Classification of Diseases system (ICD). All hospitals are obligated by law to report all cases of in-patient care, and the drop-out rate has been estimated to be \1 %; quality controls, as well as testing of the validity of all variables, are continuously conducted. A recent review suggests an overall positive predictive value of recorded diagnoses of 85-95 % [14] .
Surgery
The dominant surgical approach in this cohort (and today) is a thoraco-abdominal procedure (Ivor-Lewis) with intrathoracic anastomosis. This approach includes an abdominal procedure mobilizing the stomach and creating a gastric tube, functioning as the esophageal substitute. The thoracic procedure typically includes a right-sided posterolateral thoracic incision, allowing dissection of the esophagus and lymph nodes, and reconstruction with the pulled up gastric tube which is anastomosed to the proximal esophagus.
Study exposure: comorbidity
The study exposure was pre-defined comorbidity present before surgery. Each comorbidity was sufficiently clinically relevant since it was recorded with a diagnosis code by a physician and required active treatment. Comorbidity was categorized into 4 main groups (1) cardiac disease (angina or heart failure), (2) hypertension, (3) pulmonary disease (chronic obstructive pulmonary disease or asthma), and (4) diabetes. Additionally, ICD-codes were used to calculate the Charlson comorbidity index [15] . Patients with any previous diagnosis of esophageal cancer, gastric cancer, or metastatic cancer were excluded since esophageal cancer could be misclassified as gastric cancer before surgery and metastatic cancer could potentially include esophageal cancer. Transformation from ICD-codes to comorbidities was done according to a well-validated system [16] [17] [18] . The Charlson comorbidity index scores were calculated, and patients were divided into 3 groups: 0, 1, and C2.
Study outcome: post-operative complications
The study outcome was pre-defined complications occurring within 30 days of surgery and prospectively assessed. The 30-day assessment was used to provide a high level of accuracy of the complication assessment. The relevant complications were determined and defined by a group of experienced esophageal surgeons and researchers prior to data collection. The complications were categorized into three main groups: (1) the thoracic duct (severe chyle leak requiring drainage more than 7 days or reoperation), intra-abdominal or intrathoracic abscess (radiological or surgically verified abscess, at least 3 9 3 cm, with symptoms as fever, pain, or dyspnoea), wound rupture, wound infection (pus in the wound that gives symptoms and needs treatment), necrosis of the substitute (clinically significant ischemia with perforation or ulceration), ileus (radiological confirmed and requiring surgery), or anastomotic stricture); (2) medical (pneumonia (radiological verified with symptoms of fever, coughing, or dyspnoea), deep venous thrombosis (clinically or radiological confirmed thrombosis that needs treatment), pulmonary embolism (radiological confirmed thrombosis that needs treatment), respiratory insufficiency (requiring intubation and ventilation), sepsis (fever, chills, and verified growth of bacteria in the blood), myocardial infarction (clinically verified by ECG or enzymes), atrial fibrillation (newly diagnosed by ECG and needs treatment), cerebrovascular infarction (radiological confirmed), renal insufficiency (requiring dialysis), or liver insufficiency (progressive icterus either acute or chronic); and (3) any complications (all complications included in the two groups above, plus death within 30 days of surgery, divided into two groups (a) none or (b) at least one).
Statistical analysis
A multivariable logistic regression model was used to provide odds ratios (ORs) with 95 % confidence intervals (CIs) adjusted for potential confounding by the following variables: (1) age (continuous variable), (2) sex (male or female), (3) tumor stage (0-I, II, or III-IV), (4) tumor histology (adenocarcinoma or squamous cell carcinoma), (5) neo-adjuvant therapy (yes or no), (6) type of surgery (esophageal resection, cardia resection, extended total gastrectomy, or total gastrectomy and esophageal resection), (7) annual hospital volume of esophagectomies (based on previous studies [9, 4-9, or \4) [19, 20] , (8) comorbidity (any of the other predefined groups of comorbidities, for example, if cardiac disease was being analyzed, adjustments were made for hypertension, pulmonary disease, diabetes, and any other comorbidities), and (9) complications (in the analysis of medical and surgical complications). Further, relative risks are estimated as ORs. We also performed analyses restricted to two subgroups of patients (1) those who underwent transthoracic surgery and (2) those with data available on BMI. Additionally, to assess linear trends for Charlson comorbidity index score and risk of complications, a likelihood ratio test was performed where a non-significant p value represented a statistically significant linear trend. All statistical analyses were completed using the statistical software STATA 11 for Windows (STATA Corp, College Station, TX, USA).
Ethical considerations
Informed consent was provided and obtained from all participating patients before inclusion in the data collection. The study was approved by the Regional Ethical Review Board in Stockholm, Sweden.
Results
Patients
A total of 616 operated esophageal cancer patients were included in the original cohort. Due to missing data on tumor stage in 6 patients and missing histology in 1 patient, the final analyses were performed on 609 (99 %) patients. Characteristics of the study participants, divided by comorbidity status and post-operative complications, are presented in Table 1 . At least one comorbidity was identified in 370 (61 %) of the study participants. Patients of older age more frequently had comorbidity and complications, while the distribution of sex, tumor stage, tumor histology, operation type, and annual hospital volume was similar among patients with and without comorbidity or complications ( Table 1 ). The frequencies of surgical and medical complications are presented in Table 2 . Anastomotic insufficiency was the most frequent surgical complication (n = 52, 9 %), while the most common medical complication was respiratory insufficiency (n = 99, 16 %). The 30-day mortality rate was 3 % (n = 18), and 90-day mortality rate was 8 % (n = 48). Transthoracic resection was performed on 502 patients (82 %) of whom 70 (89 % of all patients with pulmonary comorbidity) had pulmonary comorbidity. Distribution of patients without comorbidities according to the Charlson comorbidity index was slightly different compared to the distribution of patients without pre-defined comorbidities; 322 (53 %) patients had a Charlson score of 0, while 239 (39 %) patients had no comorbidity (Table 3) . This difference is explained by the fact that the Charlson comorbidity index does not include hypertension (n = 137) but instead includes some other diseases, i.e., peripheral vascular disease, peptic ulcer disease, and connective tissue disease.
Comorbidity and risk of complications
Compared to patients without pre-defined comorbidity, patient with cardiac disease was at a nearly 2-fold increased risk of having any of the pre-defined complications (OR 1.81, 95 % CI 1.13-2.90), while no such associations were found among patients with hypertension, pulmonary disease, diabetes, or obesity ( (Table 3) .
Comorbidity and risk of medical complications
Patients with a Charlson score C2 showed an increased risk of medical complications (OR 2.23, 95 % CI 1.45-3.47). A Charlson score of 1 indicated slightly elevated risk of medical complications, while none of the studied individual comorbidities was associated with any statistically significantly increased risk of pre-defined complications (Table 3) .
Discussion
This study indicates that the presence of angina or heart failure and a higher Charlson score increase the risk of early complications after esophageal cancer surgery. Hypertension, pulmonary disease, diabetes, and obesity did not consistently or individually increase the risk of complications, except for an increased risk of surgical complications among patients with hypertension. Methodological strengths of the present study include the prospective and population-based design with a high participation rate, detailed clinical data collection, use of strict and pre-defined exposures and outcomes with strict definitions, and adjustment for several potential confounding factors. The lack of information on the severity of comorbidities is a limitation, but patients with documented comorbidity were likely to have a clinically relevant disease, and the Charlson comorbidity index takes severity into account by giving more points to more severe diseases. It might be argued that the study is out dated since the surgery was conducted during 2001-2005. However, the surgical approaches and the short-term surgical outcomes (e.g., 3 % short-term mortality) during the study period are similar to current clinical practice in Sweden and therefore applicable to patient today [21] . During recent years, more patients receive neoadjuvant treatment prior to surgery, while patients in this study almost exclusively were treated with surgery alone. This might affect the generalizability of the study, but since we are studying surgery alone as the exposure this will not affect the conclusions. Moreover, to the best of our knowledge, there are no other populationbased studies addressing this topic with better data on the study exposures, outcomes, and covariates. Although the Clavien-Dindo classification of surgical complications was not established when the cohort was created [22] , the assessment of complications was pre-defined and based on strict definitions. Moreover, the possibility of confounding by factors other than those adjusted for can never be ruled out in observational research. Finally, although the study included almost all resected patients in Sweden during a 5-year period, the low incidence of esophageal cancer in Sweden combined with a limited resection rate (25 %) reduced the sample size and the statistical power to detect weak associations [2, 23] . Yet, the main results of the study showed strong associations that were clearly statistically significant.
Only a few other large studies have addressed the role of comorbidities in relation to the risk of complications after esophageal cancer surgery. A British multicenter cohort study including 955 patients who had undergone upper gastrointestinal cancer surgery showed an increased risk of complications with a higher comorbidity score, but there were no specific data for esophageal cancer surgery [24] . Another study of 2315 patients with esophageal cancer from 73 hospitals in the United States showed an increased risk of complications among patients with several comorbidities, particularly cardiac disease, diabetes, and hypertension [24, 25] . The results from these two large studies together with the results of the present study suggest that comorbidity substantially increases the risk of post-operative complications after esophageal cancer resection [24, 25] . This should be considered during the clinical decision-making process, particularly since non-surgical treatment options, mainly definite chemo-radiotherapy, are available for a potentially curable disease [26] .
Cardiac disease was also associated with an increased risk of complications after esophageal cancer surgery in the large multicenter study from United States [25] , and a single-center study from Hong Kong found that patients who suffered technical complications after esophagectomy were more likely to have a pre-existing cardiac condition [27] . Also, patients with cardiac disease are at a higher risk of atrial fibrillation, which is a common complication after esophagectomy [28, 29] . These findings are in agreement with the results from the present study and taken together suggest that even more careful pre-operative assessment and active intervention might benefit patients with cardiac disease.
The present study indicates that patients with hypertension might have an increased risk of surgical complications, but not of medical complications. These results might partly be explained by the influence of lifestyle factors linked to hypertension, e.g., obesity and tobacco smoking. The adjustment for BMI did not change the results, but we could not adjust for potential confounding by tobacco smoking. However, an association between hypertension and post-operative complications after esophagectomy, including surgical complications, has been reported previously, and those results were adjusted for tobacco smoking [25] . Additionally, a large multicenter study including 7595 patients reported an increased risk of anastomotic leak, the most common surgical complication, for patients with hypertension [30] . The increased risk might be explained by affected microvascularisation involved in the healing of the anastomosis. Taken together, an increased risk of surgical complications among patients with hypertension cannot be dismissed but requires further investigation. This study provides no evidence of an association between diabetes and complications following esophagectomy, while previous studies addressing this relation have provided conflicting results [6, 25, 31, 32] . One explanation for the diverging results might be that the value of tight glucose control in order to avoid diabetic-linked complications has been taken more seriously during the last decade compared to earlier [33, 34] . Two of the studies showing an increased risk of complications after esophagectomy among patients with diabetes included patients with esophageal cancer before new guidelines were introduced [6, 32] , suggesting that patients in those studies did not have as well-controlled and managed diabetes as the patients in the present study.
In conclusion, this prospective and population-based Swedish cohort study indicates that patients with the cardiac conditions angina and heart failure or a Charlson score C1 are at an increased risk of early complications after esophageal cancer surgery, after adjustment for potential confounding. Existence of the comorbidities hypertension, pulmonary disease, diabetes, and obesity did not individually or consistently increase the risk of such complications, except for an increased risk of surgical complications among patients with hypertension. These findings highlight the need to optimize certain comorbidities prior to surgery. 
